HHS Seeks Another Delay Of 340B Drug Price Ceilings
The U.S. Department of Health and Human Services has again proposed delaying the implementation of a final rule that would establish drug price ceilings and fine drugmakers that knowingly charge more...To view the full article, register now.
Already a subscriber? Click here to view full article